Nabi H, Georgiadis S, Loft AG, Hendricks O, et al. Comparative effectiveness of two adalimumab biosimilars in 1318 real-world patients with inflammatory rheumatic disease mandated to switch from originator adalimumab: nationwide observational study emulating a randomised clinical trial. Ann Rheum Dis 2021;80:1400-1409.
PMID: 33926921